These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3102633)

  • 21. Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions.
    Akiyama H; Toi Y; Kanzaki H; Tada J; Arata J
    Arch Dermatol Res; 1996 Jun; 288(7):418-20. PubMed ID: 8818194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Frequency and microbiological characteristics of toxic shock syndrome toxin-1 producing Staphylococcus aureus from the vaginal fluor].
    Matsushita M
    Kansenshogaku Zasshi; 1986 Mar; 60(3):195-203. PubMed ID: 3095444
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnesium, Staphylococcus aureus and toxic shock syndrome.
    Kass EH
    Magnesium; 1988; 7(5-6):315-9. PubMed ID: 3075248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview.
    Schlievert PM
    Rev Infect Dis; 1989; 11 Suppl 1():S107-9. PubMed ID: 2648535
    [No Abstract]   [Full Text] [Related]  

  • 25. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide.
    Ross RA; Onderdonk AB
    Infect Immun; 2000 Sep; 68(9):5205-9. PubMed ID: 10948145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus.
    Taylor D; Holland KT
    J Appl Bacteriol; 1989 Apr; 66(4):319-29. PubMed ID: 2753836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
    Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
    J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of staphylococcal toxic shock syndrome toxin-1 and total exoprotein production by magnesium ion.
    Mills JT; Dodel AW; Kass EH
    Infect Immun; 1986 Sep; 53(3):663-70. PubMed ID: 3527988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics and expression of toxic shock syndrome toxin 1: overview.
    Kreiswirth BN
    Rev Infect Dis; 1989; 11 Suppl 1():S97-100. PubMed ID: 2648542
    [No Abstract]   [Full Text] [Related]  

  • 32. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production.
    Flood JA; Tripp TJ; Davis CC; Hill DR; Schlievert PM
    J Microbiol Methods; 2004 May; 57(2):283-8. PubMed ID: 15063069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The toxic shock syndrome revisited.
    Kass EH
    Postgrad Med J; 1985; 61 Suppl 1():45-8. PubMed ID: 4059159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
    Holland KT; Taylor D; Farrell AM
    J Antimicrob Chemother; 1994 Jan; 33(1):41-55. PubMed ID: 8157573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
    Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
    Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An outbreak of enteritis induced by methicillin-resistant Staphylococcus aureus producing enterotoxin types A and C, toxic shock syndrome toxin-1 and coagulase type II.
    Kaneko A; Mori T; Fujino T; Nakamura A; Naiki Y; Mutoh M; Nagata A; Kirikae T
    Jpn J Infect Dis; 2000 Oct; 53(5):212-4. PubMed ID: 11135710
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
    Remington KM; Buller RS; Kelly JR
    Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoblots for detection of toxic shock syndrome toxin 1 produced by Staphylococcus aureus.
    Weckbach LS; Staneck JL; Thompson MR; Bonventre PF
    J Clin Microbiol; 1990 Jun; 28(6):1488-90. PubMed ID: 2380373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.